Senseonics Holdings Inc (SENS)
0.3227
+0.01
(+1.70%)
USD |
NYAM |
Nov 21, 16:00
0.322
0.00 (0.00%)
Pre-Market: 08:03
Senseonics Holdings Gross Profit Margin (Quarterly): -95.03% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -95.03% |
| June 30, 2024 | 6.13% |
| March 31, 2024 | 6.64% |
| December 31, 2023 | 13.56% |
| September 30, 2023 | 19.22% |
| June 30, 2023 | 10.11% |
| March 31, 2023 | 10.01% |
| December 31, 2022 | 11.11% |
| September 30, 2022 | 16.36% |
| June 30, 2022 | 22.19% |
| March 31, 2022 | 21.24% |
| December 31, 2021 | -12.05% |
| September 30, 2021 | -35.28% |
| June 30, 2021 | 11.92% |
| March 31, 2021 | 18.48% |
| December 31, 2020 | 66.31% |
| September 30, 2020 |
| Date | Value |
|---|---|
| June 30, 2020 | -437.9% |
| March 31, 2020 | -54.54K% |
| December 31, 2019 | -92.10% |
| September 30, 2019 | -77.33% |
| June 30, 2019 | -98.83% |
| March 31, 2019 | -96.70% |
| December 31, 2018 | -69.38% |
| September 30, 2018 | -50.10% |
| June 30, 2018 | -5.96% |
| March 31, 2018 | -12.29% |
| December 31, 2017 | -38.95% |
| September 30, 2017 | -41.01% |
| June 30, 2017 | -110.6% |
| March 31, 2017 | -88.97% |
| December 31, 2016 | -85.51% |
| September 30, 2016 | -208.1% |
| June 30, 2016 | -78.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-54.54K%
Minimum
Mar 2020
66.31%
Maximum
Dec 2020
-2.89K%
Average
10.11%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.83% |
| DexCom Inc | 59.73% |
| Baxter International Inc | 38.27% |
| Boston Scientific Corp | 68.83% |
| Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -445.2% |
| Return on Assets | -64.09% |
| Return on Invested Capital | -121.5% |
| Profit Margin (Quarterly) | -562.4% |
| Operating Margin (Quarterly) | -535.9% |
| Return on Net Operating Assets | -384.8% |